Results 1–20 of 160 for evusheld in the 'Written Answers'

Written Answers — Department of Health and Social Care: Coronavirus: Immunosuppression (1 Feb 2023)

Lord Markham: ...to generate antibodies following vaccination and 40% mounted a low serological response. The National Institute for Health and Care Excellence (NICE) is conducting a Health Technology Evaluation of Evusheld, which will provide guidance on the use of Evusheld within the NHS. Part of this evaluation will include consideration of the cohorts that could benefit if NICE recommends its use as a...

Written Answers — Department of Health and Social Care: Coronavirus: Kidney Diseases (27 Jan 2023)

Will Quince: ...treatments have been deemed unsuitable. The National Institute for Health Excellence (NICE) is currently evaluating the treatments for COVID-19, including existing antiviral treatments, as well as Evusheld as a prophylactic. If NICE finds the medicines clinically and cost effective, the National Health Service will make them available as appropriate. We are also exploring options for an...

Written Answers — Department of Health and Social Care: Members: Correspondence (26 Jan 2023)

Tim Loughton: ...for Health and Social Care, with reference to the correspondence from the hon. Member for East Worthing and Shoreham of 6 September 2022 and 1 November 2022, for what reason (a) he will not meet Evusheld campaigners and (b) his correspondence of 15 December 2022 did not refer to the request for a meeting.

Written Answers — Department of Health and Social Care: Evusheld (24 Jan 2023)

Ben Bradshaw: To ask the Secretary of State for Health and Social Care, what criteria his Department uses to assess the cost-effectiveness of the use of Evusheld against the cost of admission to a hospital for an immune-compromised person with complex health conditions.

Written Answers — Department of Health and Social Care: Evusheld (23 Jan 2023)

the Bishop of Exeter: To ask His Majesty's Government what assessment they have made of the cost effectiveness of Evusheld in the treatment of immuno-compromised persons with complex health needs against the cost of an admission to hospital, given the increase in COVID-19 hospital admissions and the pressure on the NHS.

Written Answers — Department of Health and Social Care: Evusheld (16 Jan 2023)

Mark Pritchard: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of NICE bringing forward proposals to support the introduction of next generation of Evusheld to offer protection against covid-19 for those people for whom traditional covid-19 vaccines offer limited or no protection.

Written Answers — Department of Health and Social Care: Evusheld (20 Dec 2022)

Daisy Cooper: To ask the Secretary of State for Health and Social Care, if he will publish a list of all available world-wide source material on the effectiveness of Evusheld and within that list, to identify which source material, if any, were excluded by Rapid C-19 when producing advice on Evusheld procurement to Ministers, and on what criterion.

Written Answers — Department of Health and Social Care: Evusheld (9 Dec 2022)

Lord Mendelsohn: To ask His Majesty's Government whether they will ensure that immunocompromised patients will have to wait no more than nine months from approval to get the prophylactic antibodies Evusheld.

Written Answers — Department of Health and Social Care: Coronavirus: Disease Control (7 Dec 2022)

Thangam Debbonaire: To ask the Secretary of State for Health and Social Care, with reference to the Government's decision on Evusheld, what steps he is taking to help protect those people acutely vulnerable to covid-19.

Written Answers — Department of Health and Social Care: Evusheld (28 Nov 2022)

Lord Mendelsohn: ...Majesty's Government what papers and data were consulted in advance of the Secretary of State for Health and Social Care and Chief Medical Officer taking the decision not to pursue procurement of Evusheld; and what is the most recent real time evidence of Evusheld’s effectiveness that they have consulted.

Written Answers — Department of Health and Social Care: Evusheld (28 Nov 2022)

Lord Mendelsohn: ...Majesty's Government what plans they have to undertake an equalities assessment on the availability of protection from COVID-19, given that immunocompromised and vulnerable patients' only access to Evusheld costs up to £3,000 on the private market.

Written Answers — Department of Health and Social Care: Coronavirus: Vaccination (28 Nov 2022)

Lord Markham: ...expertise in the therapeutic options available and consults experts in an NHS expert working group and the Prophylaxis Oversight Group. The Chief Medical Officer for England has agreed that Evusheld should be referred to the National Institute for Health and Care Excellence for further evaluation, which is underway

Written Answers — Department of Health and Social Care: Evusheld (28 Nov 2022)

Baroness Whitaker: To ask His Majesty's Government what assessment they have made of the number of immunocompromised people in England who could potentially benefit from Evusheld if it is found to be appropriate for prescription on the NHS.

Written Answers — Department of Health and Social Care: Evusheld (28 Nov 2022)

Baroness Whitaker: To ask His Majesty's Government why, given that Evusheld has been approved for private prescription, it has not yet been approved for prescription on the NHS.

Written Answers — Department of Health and Social Care: Evusheld (28 Nov 2022)

Baroness Whitaker: To ask His Majesty's Government when they expect a decision to be made as to the suitability of prescribing Evusheld on the NHS.

Written Answers — Department of Health and Social Care: Evusheld (22 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government whether a recommendation by Rapid C-19 is stopping the provision of Evusheld in the NHS by Christmas.

Written Answers — Department of Health and Social Care: Evusheld (22 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government whether Evusheld will be available to NHS patients before Christmas.

Written Answers — Department of Health and Social Care: Evusheld (22 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government whether they will rule out the possibility that patients will receive a placebo in place of Evusheld.

Written Answers — Department of Health and Social Care: Evusheld (22 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government what discussions they have had with experts in any of the 32 countries using Evusheld on their real time testing and trials.

Written Answers — Department of Health and Social Care: Evusheld (18 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government, further to the report RAPID C-19 Oversight Group report: review of Evusheld by the RAPID C-19 Oversight Group, published on 6 October, how many members of the RAPID C-19 Oversight Group were (1) full time clinicians or doctors, and (2) clinicians who treat immunocompromised patients.


1 2 3 4 5 6 7 8 > >>

Create an alert

Advanced search

Find this exact word or phrase

You can also do this from the main search box by putting exact words in quotes: like "cycling" or "hutton report"

By default, we show words related to your search term, like “cycle” and “cycles” in a search for cycling. Putting the word in quotes, like "cycling", will stop this.

Excluding these words

You can also do this from the main search box by putting a minus sign before words you don’t want: like hunting -fox

We also support a bunch of boolean search modifiers, like AND and NEAR, for precise searching.

Date range

to

You can give a start date, an end date, or both to restrict results to a particular date range. A missing end date implies the current date, and a missing start date implies the oldest date we have in the system. Dates can be entered in any format you wish, e.g. 3rd March 2007 or 17/10/1989

Person

Enter a name here to restrict results to contributions only by that person.

Section

Restrict results to a particular parliament or assembly that we cover (e.g. the Scottish Parliament), or a particular type of data within an institution, such as Commons Written Answers.

Column

If you know the actual Hansard column number of the information you are interested in (perhaps you’re looking up a paper reference), you can restrict results to that; you can also use column:123 in the main search box.